Educational Program in Younger Women Who Have Recently Finished Treatment for Stage I or Stage II Breast Cancer
Adjustment to Breast Cancer Among Younger Women
2 other identifiers
interventional
252
0 countries
N/A
Brief Summary
RATIONALE: Educational programs may improve coping and quality of life in younger women who have recently been treated for early-stage breast cancer. PURPOSE: To conduct a clinical trial to determine if an educational intervention and a nutritional intervention could enhance physical and psychological functioning among younger women completing treatment for early-stage breast cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 1997
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 1997
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2001
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2006
CompletedFirst Submitted
Initial submission to the registry
December 27, 2006
CompletedFirst Posted
Study publicly available on registry
December 28, 2006
CompletedResults Posted
Study results publicly available
November 7, 2016
CompletedNovember 7, 2016
September 1, 2016
4.3 years
December 27, 2006
August 25, 2015
September 21, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Depressive Symptoms (Measured With an Abbreviated 10-item CES-D) at Baseline, Post-intervention (4-months Post-intervention) and Final Follow-up (13-months Post-intervention).
Scores for the shortened form of the Center for Epidemiologic Studies Depression scale(CES-D) ranged from 0 (no depressive symptoms) to 24 (high levels of depressives symptoms) in the present sample.
Baseline, Post-intervention(4 months post-intervention) and Final Follow-up(13 months post-intervention).
Perceived Physical Health (Measured With SF-36) at Baseline, Post-intervention (4-months Post-intervention) and Final Follow-up (13-months Post-intervention)
The Perceived Physical Health Component scale of the Medical Outcomes Study Short Form 36 (SF-36) consists of a norm-based weighted average of the following subscales: Physical functioning, bodily pain, role limitations due to physical problems and general health. In the present study, scores ranged from a maximum of 68 (high levels of perceived health) to a minimum of 24 (low levels of perceived health).
Baseline, Post-intervention(4 months post-intervention), and Final Follow-up(13 months post-intervention)
Mental Health (Measured With the SF-36) at Baseline, Post-intervention (4-months Post-intervention) and Final Follow-up (13-months Post-intervention)
The Mental Health Component Scale of the Medical Outcomes Study Short Form 36 (SF-36) consists of a norm-based weighted average of the following subscales: vitality, social functioning, role limitations due to emotional problems and mental health. In the present study, scores ranged from a maximum of 68 (high levels of mental health) to a minimum of 15 (low levels of mental health).
Baseline, Post-intervention(4 months post-intervention), Final Follow-up(13 months post-intervention)
Study Arms (3)
Education Intervention
EXPERIMENTALParticipants attended 4 2-hr education sessions. The overall goal of the sessions was to provide information that would reduce participants' uncertainty about their illness and its treatment, to enhance coping in productive ways with the issues and problems confronting them, and to facilitate communication between the participants and their partners.
Nutrition Education Intervention
EXPERIMENTALParticipants attended 4 2-hr nutrition education sessions. Each session provided information and encouragement on setting and attaining measurable goals for healthy eating and on the benefits of thinking positively about dealing adaptively with problems in life and living a healthy lifestyle.
Control Condition
NO INTERVENTIONParticipants received care as usual.
Interventions
Sessions were led by two professionals with expertise in the topic. The sessions began a with presentation of informational material followed by guided discussion of related topics. The first session discussed what to say and not say to children about cancer and how to create a safe environment for them; the second session discussed carrying on with life after the diagnosis of breast cancer, including strategies for managing stress and anxiety and developing meaning in life; the third session talked about how to maintain closeness with a partner and ways to talk about breast cancer; the last session focused on the effects of treatment on reproductive status, and the genetic bases of breast cancer. Participants were also given related booklets and brochures to take home to read.
The nutrition sessions were presented by a professional trained in nutritional science. Sessions included the presentation of information and guided discussion of related topics. The first session discussed information on choosing fruits, vegetables, and low-fat foods and incorporating them into a diet; the second session involved a demonstration of low-fat cooking methods; the third session provided information on the nutritional make-up of a healthy diet and how to shop for it; the last session included information on how to maintain a healthy, low-fat diet while eating out. Women were also asked to keep a four-day food diary, to focus them on their dietary intake and control over it.
Eligibility Criteria
You may qualify if:
- Diagnosis of breast cancer
- Stage I or II disease
- No more than 10 positive lymph nodes
- First-time diagnosis
- Under the age of 50 at diagnosis
- Finished active treatment within the past 2 months
- English-speaking only
- Must live within 30 miles of Magee Women's Hospital, Pittsburgh, Pennsylvania
- Female patients only
- Must be able to communicate
You may not qualify if:
- Other prior malignancies except skin cancer
- PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Carnegie Mellon Universitylead
- National Cancer Institute (NCI)collaborator
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Michael F. Scheier, PhD
- Organization
- Carnegie Mellon University
Study Officials
- STUDY CHAIR
Michael Scheier, PhD
Pittsburgh Mind-Body Center at Carnegie Mellon University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Psychology
Study Record Dates
First Submitted
December 27, 2006
First Posted
December 28, 2006
Study Start
January 1, 1997
Primary Completion
May 1, 2001
Study Completion
April 1, 2006
Last Updated
November 7, 2016
Results First Posted
November 7, 2016
Record last verified: 2016-09